Angela Wardman

563 total citations
6 papers, 455 citations indexed

About

Angela Wardman is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Angela Wardman has authored 6 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Molecular Medicine and 5 papers in Epidemiology. Recurrent topics in Angela Wardman's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Pneumonia and Respiratory Infections (3 papers). Angela Wardman is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Pneumonia and Respiratory Infections (3 papers). Angela Wardman collaborates with scholars based in United Kingdom, United States and Israel. Angela Wardman's co-authors include Paul Newell, Leanne B. Gasink, J. Armstrong, Greg Stone, Peter J. Laud, Yehuda Carmeli, Gregory G. Stone, Helen Broadhurst, Katrina Yates and Joseph W. Chow and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Lancet Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Angela Wardman

6 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela Wardman United Kingdom	5	398	296	181	170	48	6	455
Vassiliki Papaioannou Greece	5	374 0.9×	196 0.7×	172 1.0×	159 0.9×	69 1.4×	5	420
Katrina Yates United Kingdom	7	408 1.0×	342 1.2×	240 1.3×	173 1.0×	40 0.8×	8	498
Valentina Galfo Italy	10	346 0.9×	205 0.7×	115 0.6×	162 1.0×	73 1.5×	18	443
Christopher Cortes United States	6	407 1.0×	283 1.0×	121 0.7×	146 0.9×	58 1.2×	7	437
Paola Elvira Mocavero Italy	5	287 0.7×	196 0.7×	135 0.7×	93 0.5×	48 1.0×	6	351
Maria Katsiari Greece	9	348 0.9×	208 0.7×	162 0.9×	88 0.5×	73 1.5×	20	404
Julia Guzmán-Puche Spain	9	277 0.7×	138 0.5×	107 0.6×	130 0.8×	55 1.1×	23	321
Martha Nepka Greece	4	449 1.1×	281 0.9×	172 1.0×	150 0.9×	79 1.6×	6	522
Ángela Cano Spain	10	278 0.7×	138 0.5×	118 0.7×	141 0.8×	42 0.9×	24	326
Henrietta Abodakpi United States	10	497 1.2×	353 1.2×	160 0.9×	193 1.1×	78 1.6×	12	563

Countries citing papers authored by Angela Wardman

Since Specialization

Citations

This map shows the geographic impact of Angela Wardman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Wardman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Wardman more than expected).

Fields of papers citing papers by Angela Wardman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Wardman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Wardman. The network helps show where Angela Wardman may publish in the future.

Co-authorship network of co-authors of Angela Wardman

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Wardman. A scholar is included among the top collaborators of Angela Wardman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Wardman. Angela Wardman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

Cheng, Karen, Paul Newell, Joseph W. Chow, et al.. (2020). Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme. Drug Safety. 43(8). 751–766. 18 indexed citations

Nichols, Wright W., Gregory G. Stone, Paul Newell, et al.. (2018). Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 62(11). 28 indexed citations

Stone, Gregory G., Paul Newell, Leanne B. Gasink, et al.. (2018). Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme. Journal of Antimicrobial Chemotherapy. 73(9). 2519–2523. 65 indexed citations

Carmeli, Yehuda, J. Armstrong, Peter J. Laud, et al.. (2016). Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. The Lancet Infectious Diseases. 16(6). 661–673. 319 indexed citations

Stone, Gregory G., Leanne B. Gasink, Paul Newell, et al.. (2016). Efficacy of Ceftazidime-Avibactam against Multi-Drug Resistant Enterobacteriaceae and Pseudomonas aeruginosa from the Phase 3 Clinical Trial Program. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations

Stone, Gregory G., Patricia A. Bradford, Paul Newell, & Angela Wardman. (2016). In Vitro Activity of Ceftazidime-Avibactam against Isolates in a Phase 3 Open-Label Clinical Trial for Complicated Intra-Abdominal and Urinary Tract Infections Caused by Ceftazidime-Nonsusceptible Gram-Negative Pathogens. Antimicrobial Agents and Chemotherapy. 61(2). 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact